Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Hemolytic Disease of Newborn
NCT03130517Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Jul 2017
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, open-label trial of intravenous immunoglobulin G in hemolytic disease of the newborn (HDN) (2 arms), sponsored by Assiut University. Primary endpoint: Duration of phototherapy. Status: unknown.
02
Drugs
intravenous immunoglobulin G
03
Conditions
hemolytic disease of the newborn (HDN)
Beyond the preview
Go deeper on NCT03130517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130517.